These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1818930)

  • 1. Insulin response to oral glucose in essential hypertensives with increased circulating levels of insulin growth factor I.
    Diez J; Ruilope LM; Rodicio JL
    J Hypertens Suppl; 1991 Dec; 9(6):S174-5. PubMed ID: 1818930
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma insulin and blood pressure response to oral glucose tolerance test in young borderline hypertensives.
    Narkiewicz K; Rynkiewicz A; Furmański J; Gan J; Narwojsz E; Bieniaszewski L; Krupa-Wojciechowska B
    Mater Med Pol; 1993; 25(1):23-6. PubMed ID: 8412338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative effects of captopril and chlorthalidone on glucose tolerance and insulin levels essential hypertensives].
    Zanella MT; Baptista M; Costa CH; Kohlmann NE; Kohlmann Júnior O; Ribeiro AB
    Arq Bras Cardiol; 1996 Jul; 67(1):47-52. PubMed ID: 9035467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives.
    Egan BM; Stepniakowski K
    J Hypertens; 1994 Sep; 12(9):1061-7. PubMed ID: 7852750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The change in the circulating insulin-like growth factor binding protein 1 isoform pattern during the course of oral glucose tolerance test.
    Nedić O; Masnikosa R
    Metabolism; 2008 May; 57(5):658-61. PubMed ID: 18442629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
    Hunt KJ; Lukanova A; Rinaldi S; Lundin E; Norat T; Palmqvist R; Stattin P; Riboli E; Hallmans G; Kaaks R
    Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of fasting and post oral glucose serum insulin levels in hypertensive and obese subjects.
    Kothari K; Mathur A; Yadav S
    J Assoc Physicians India; 1998 Jun; 46(6):514-7. PubMed ID: 11273248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of glucose, insulin and somatotropin hormone in patients with hyperbilirubinemia during the oral glucose tolerance test].
    Weber P; Martínek K; Kolácný I; Cechácek Z
    Vnitr Lek; 1987 Jul; 33(7):593-600. PubMed ID: 3310389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Does long-term blood pressure reduction in patients with essential hypertension improve concomitant metabolic disorders?].
    Hauner H; Meissner C
    Med Klin (Munich); 1994 Aug; 89(8):403-9. PubMed ID: 7968872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of blood sugar and blood insulin levels in the oral glucose tolerance test].
    Aiello CR; Turner D; Aparicio NJ; De Turner EA; Vazquez A
    Medicina (B Aires); 1974 Mar; 34(2):119-26. PubMed ID: 4848680
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin resistance and beta-cell hypersecretion in essential hypertension.
    Sechi LA; Tedde R; Marigliano A; Melis A; Pala A; Orecchioni C
    J Hypertens Suppl; 1990 Sep; 8(4):S87-9. PubMed ID: 2258791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma immunoreactive insulin level and glucose tolerance in hypertension.
    Vaish SK; Dubey KP; Tiwari PL; Mohan M
    Indian Heart J; 1973 Oct; 25(4):308-13. PubMed ID: 4789731
    [No Abstract]   [Full Text] [Related]  

  • 15. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
    Haenni A; Lithell H
    J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digitalis-like factor response to hyperinsulinemia in human pregnancy, a model of insulin resistance.
    Seely EW; Carroll JA; Goodfriend TL; Tao QF; Graves W
    J Hum Hypertens; 2002 Dec; 16(12):851-6. PubMed ID: 12522466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The assessment of glucose tolerance in hypertensive subjects treated with amlodipine].
    Panuccio D; Romani A; Trabatti MR; Romanelli R; Nardi R
    Clin Ter; 1993 Oct; 143(4):309-13. PubMed ID: 8258265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement in glucose tolerance and insulin sensitivity after a single administration of tolbutamide in hypertensive patients].
    Dzúrik R; Dzúriková K; Spustová V
    Vnitr Lek; 1991 Mar; 37(3):255-60. PubMed ID: 2031314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of glucose load on cardiovascular and humoral responses to a cold pressure test.
    Stornello M; Valvo EV; Distefano M; Golino M; Cocuzza F; Vasques E; Modicano V; Leone S; Giustolisi V
    J Hum Hypertens; 1995 Feb; 9(2):93-9. PubMed ID: 7752181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.